Biolase Inc Expected To Post A Loss Of $5.33 A Share: Earnings Preview

November 26

09/08/2023 03:01

* BIOLASE Inc  BIOL.OQ   BIOL.O  is expected to show a rise
in
quarterly revenue when it reports  results on August 10. 
    * The Foothill Ranch California-based  company is expected
to
report  a 25.5% increase in revenue to $15.357 million from
$12.24 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for BIOLASE Inc is for
a loss
of $5.33 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$35​, above​ its last closing price of $6.79. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -21.31      -19.67     -18.00    Beat    8.5
 Dec. 31 2023  -64.18      -63.67     -1.28     Missed  -101
                                      hundred           
 Sep. 30 2022  -84.76      -84.33     -1.10     Missed  -30.4​
                                      hundred           
 Jun. 30 2022  -63.50      -62.25     -91.00    Missed  -46.2
 ​​Mar.        -79.00      -68.00     -81.00    Missed  -19.1
 31 2022                                                
 Dec. 31 2021              -62.50     -75.00    Missed  -20​
 Sep. 30 2021  -61.95      -68.75     -50.00    Beat    27.3
 Jun. 30 2021  -1.13       -1.08      -50.00    Beat    53.8
               hundred     hundred                      
 This summary was machine generated August 9 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated